UCL Ear Institute


Tanjinah Ferdous

NIHR CRN Research Audiologist

In February 2018 I joined the evidENT team at the UCL Ear Institute as an NIHR CRN Research Audiologist, where I provide audiology research support for a range of hearing studies at the Royal National Throat, Nose and Ear Hospital (RNTNEH). Examples include the set up and delivery of the SeaSHeL study, a nationwide prospective cohort study of adult patients presenting with sudden sensorineural hearing loss within the NHS. This study will run in parallel with the AUDIBLE-S phase II trial of a novel drug for patients with sudden sensorineural hearing loss (sponsored by Sensorion), for which I am the Research Audiologist.

I was recently awarded an Action on Hearing Loss grant to conduct a pilot study to investigate the use of self-administered out-of-booth audiometry and serum prestin in monitoring ototoxicity in patients with sarcoma receiving cisplatin chemotherapy. This study will allow us to prepare our ENT, audiology and oncology team for a range of upcoming trials in this field. I also support the following studies: REGAIN, EVOTION, and A Molecular and Genetic Analysis of Otosclerosis. I co-authored an article for the Hearing Research journal: Early phase trials of novel hearing therapeutics - avenues and opportunities.

I have been appointed as the NIHR LCRN North Thames Audiology Champion supporting and creating capacity and capability in hearing research within the region. I work with fellow NIHR LCRN Audiology Champions across the UK to promote hearing research nationally. Alongside my role within evidENT I also work as a Specialist Audiologist in the Adult Diagnostics Audiology team at the RNTNEH.